Dave is the Chief Financial Officer of CHV. He is responsible for the financial management, reporting, audit, tax, and administrative functions of CHV and brings 20 years of finance, legal and operational experience to the firm.
Prior to joining CHV, Dave held senior roles at two of Catalyst’s portfolio companies, serving most recently as Chief Operating Officer at PanTher Therapeutics after previously serving as Chief Financial Officer at Lantos Technologies. Prior to that, he was the Chief Financial Officer at AgNovos Healthcare, where he led financial and administrative operations.
Before working in industry, Dave was an investment banker at J.P. Morgan in New York, where he advised companies and investment firms on mergers, acquisitions, divestitures, IPOs, follow-on offerings, and debt financings. He began his career as a corporate attorney at Gibson, Dunn & Crutcher, where he focused his practice on M&A and securities offerings.
Dave received a J.D. from the University of Pennsylvania School of Law and a B.A. from Colorado State University.
